More launches seen in association with higher Gross National Income per capita; shorter delays linked to cancer incidence ...

HealthDay News — From 1999 to 2018, there was a decrease in vitamin A, vitamin C, and iron intake among pregnant and nonpregnant women, according to a study published online October 10 in JAMA Network ...

Paclitaxel protein-bound particles for injectable suspension (albumin-bound) is a microtubule inhibitor indicated for the treatment of metastatic breast cancer, after failure of combination ...

Hematologic cancer developed in seven of 67 patients with cerebral adrenoleukodystrophy receiving eli-cel gene therapy ...

Supplies of a significant number of IV solutions have been impacted by Hurricane Helene; First at-home COVID-19/Flu over-the-counter antigen test gains market authorization; DOJ clamp down on fake ...

Itovebi is supplied as a tablet in 2 dosage strengths: 3mg and 9mg. Patients should be selected for treatment based on the presence of 1 or more PIK3CA mutations in plasma specimens. The FDA has ...

The Breakthrough Therapy designation is supported by positive interim data from the phase 2b VANTAGE study (ClinicalTrials.gov Identifier: NCT05050136) that evaluated the efficacy and safety of ...

HealthDay News — Dronabinol is safe and effective for the treatment of Alzheimer disease with agitation (Agit-AD), according to a study presented at the annual meeting of the International ...

The Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for elinzanetant for the treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause.

The impact of Hurricane Helene has led to a temporary supply disruption at the Baxter facility in Marion, North Carolina. The facility manufactures a significant portion of IV solutions, irrigation ...

The Food and Drug Administration (FDA) has granted Fast Track designation to liafensine (DB104) for patients with treatment-resistant depression (TRD).

"Rigorous evidence suggests that the FDA's most serious ongoing youth antidepressant warnings have not had the intended outcome of increased monitoring for suicidal thoughts and behaviors." HealthDay ...